Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Dry Eye Disease Market
Increasing prevalence of eye-related diseases is anticipated to drive the market share. The global population is experiencing a significant increase in the aging demographic. With age, the risk of developing eye-related diseases, including dry eye disease, increases significantly. The prevalence of dry eye disease tends to be higher in older individuals. For instance, according to an article published by the Karger Journal, in 2022 the prevalence rate of dry eye disease among people aged above 50 years in Asia was estimated to be around 50% and is expected in increase in the coming years.
This high prevalence rate is set to augment the demand for dry eye disease treatment products globally. Prolonged screen time and decreased blink rate associated with digital device use can contribute to dry eye symptoms. The increasing dependence on digital devices has resulted in a higher prevalence of dry eye disease among all age groups.
Dry eye disease often coexists with other systemic conditions, such as autoimmune diseases, diabetes, and thyroid disorders. The rising prevalence of these comorbidities contributes to the increasing prevalence of dry eye disease. There has been a growing awareness and understanding of dry eye disease among both healthcare professionals and the general population. Increased knowledge about the condition has led to improved diagnosis rates. Eye care professionals are better equipped to identify and diagnose dry eye disease, leading to a higher reported prevalence.